Understanding RAGE, the receptor for advanced glycation end products

Administration of the receptor decoy, sRAGE, is likely to sequester ligands, thereby preventing their interaction with other receptors in addition to RAGE, suggesting that, just as RAGE is a multiligand receptor, its ligands are also likely to recognize several receptors in mediating their biologic effects.